Flame retardants in placenta and breast milk and cryptorchidism in newborn boys

Katharina Maria Main1, Hannu Kiviranta, Helena Eeva Virtanen

  • 1University Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark. katharina.main@rh.regionh.dk

Insights

Exposure to polybrominated diphenyl ethers (PBDEs) in breast milk, but not placenta, was linked to cryptorchidism in a Danish-Finnish study. These findings are concerning due to high human PBDE exposure levels.

Area of Science:

  • Environmental Health
  • Reproductive Toxicology
  • Pediatric Endocrinology

Background:

  • Polybrominated diphenyl ethers (PBDEs) are flame retardants with widespread use in Western countries.
  • Increasing prevalence of cryptorchidism (testicular maldescent) necessitates investigation into potential environmental causes.
  • PBDEs are persistent organic pollutants that can bioaccumulate and biomagnify in humans.

Purpose of the Study:

  • To investigate the association between prenatal exposure to PBDEs and the risk of congenital cryptorchidism.
  • To analyze PBDE levels in placenta and breast milk as proxies for prenatal and early postnatal exposure.
  • To examine the relationship between PBDE exposure and specific reproductive hormone levels in infant serum.

Main Methods:

  • Prospective cohort study conducted in Denmark and Finland from 1997 to 2001.
  • Inclusion of 95 boys with cryptorchidism and 185 healthy controls for placental analysis.
  • Analysis of 14 PBDE congeners in placenta, breast milk, and infant serum, alongside reproductive hormone measurements.

Main Results:

  • No significant association was found between PBDE concentrations in placenta and cryptorchidism.
  • Significantly higher concentrations of total PBDEs were detected in breast milk of boys with cryptorchidism compared to controls.
  • A positive correlation was observed between the sum of PBDEs in breast milk and serum luteinizing hormone levels.

Conclusions:

  • Breast milk PBDE levels, unlike placental levels, showed an association with congenital cryptorchidism.
  • The findings suggest a potential role of PBDEs in the development of testicular maldescent.
  • Further research is warranted to elucidate the mechanisms and confirm these findings, considering other contributing environmental factors.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...